Literature DB >> 34387409

A clinical overview of non-alcoholic fatty liver disease: A guide to diagnosis, the clinical features, and complications-What the non-specialist needs to know.

Mark D Muthiah1,2, Ng Cheng Han1, Arun J Sanyal3.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) has a rapidly rising prevalence worldwide and is the most common cause of liver disease in developed countries. In this article, we discuss the spectrum of disease of NAFLD with a focus on the earlier spectrum of the disease that is commonly encountered by non-specialists, as well as the hepatic and extra-hepatic associations of the disease. We discuss in detail the two common presentations of NAFLD, incidentally detected hepatic steatosis and asymptomatic raised liver enzymes, and provide an algorithm for management and continued to follow up for these patients. Considerations for the management of cardiovascular comorbidities in these patients are also discussed. Finally, we cover the topic of screening for NAFLD in high-risk populations.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  energy regulation; fatty liver disease; insulin resistance; liver; primary care

Mesh:

Year:  2021        PMID: 34387409     DOI: 10.1111/dom.14521

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  9 in total

1.  The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease.

Authors:  Cheng Han Ng; Kai En Chan; Yip Han Chin; Rebecca Wenling Zeng; Pei Chen Tsai; Wen Hui Lim; Darren Jun Hao Tan; Chin Meng Khoo; Lay Hoon Goh; Zheng Jye Ling; Anand Kulkarni; Lung-Yi Loey Mak; Daniel Q Huang; Mark Chan; Nicholas Ws Chew; Mohammad Shadab Siddiqui; Arun J Sanyal; Mark Muthiah
Journal:  Clin Mol Hepatol       Date:  2022-05-19

2.  Association Between Monocyte to High-Density Lipoprotein Cholesterol Ratio and Risk of Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study.

Authors:  Liping Wang; Jinzhong Dong; Miao Xu; Li Li; Naibin Yang; Guoqing Qian
Journal:  Front Med (Lausanne)       Date:  2022-05-19

3.  Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals.

Authors:  Ansel Shao Pin Tang; Kai En Chan; Jingxuan Quek; Jieling Xiao; Phoebe Tay; Margaret Teng; Keng Siang Lee; Snow Yunni Lin; May Zin Myint; Benjamin Tan; Vijay K Sharma; Darren Jun Hao Tan; Wen Hui Lim; Apichat Kaewdech; Daniel Huang; Nicholas Ws Chew; Mohammad Shadab Siddiqui; Arun J Sanyal; Mark Muthiah; Cheng Han Ng
Journal:  Clin Mol Hepatol       Date:  2022-03-02

Review 4.  Bile Acid Receptors and the Gut-Liver Axis in Nonalcoholic Fatty Liver Disease.

Authors:  Rui Xue; Lianyong Su; Shengyi Lai; Yanyan Wang; Derrick Zhao; Jiangao Fan; Weidong Chen; Phillip B Hylemon; Huiping Zhou
Journal:  Cells       Date:  2021-10-20       Impact factor: 7.666

5.  Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria.

Authors:  Jae Seung Lee; Hye Won Lee; Beom Kyung Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Jae Young Jang; Soo Young Park; Hyun Woong Lee; Chun Kyon Lee; Seung Up Kim
Journal:  Front Med (Lausanne)       Date:  2022-04-14

6.  Dietary Acid Load (DAL), Glycated Hemoglobin A1c (HbA1c), and Metabolic Syndrome (MeS) Mediate the Association of the Adherence to the Dietary Approaches to Stopping Hypertension (DASH) and Mediterranean Diet (MeD) With Nonalcoholic Fatty Liver Disease.

Authors:  Azam Doustmohammadian; Sakineh Nouri Saeidlou; Saeed Esfandyari; Esmaeel Gholizadeh; Mansooreh Maadi; Nima Motamed; Hossein Ajdarkosh; Mahmoodreza Khoonsari; Cain C T Clark; Farhad Zamani
Journal:  Front Nutr       Date:  2022-07-07

7.  Historical Changes in Weight Classes and the Influence of NAFLD Prevalence: A Population Analysis of 34,486 Individuals.

Authors:  Benjamin Kai Yi Nah; Cheng Han Ng; Kai En Chan; Caitlyn Tan; Manik Aggarwal; Rebecca Wenling Zeng; Jieling Xiao; Yip Han Chin; Eunice X X Tan; Yi Ping Ren; Douglas Chee; Jonathan Neo; Nicholas W S Chew; Michael Tseng; Mohammad Shadab Siddiqui; Arun J Sanyal; Yock Young Dan; Mark Muthiah
Journal:  Int J Environ Res Public Health       Date:  2022-08-11       Impact factor: 4.614

8.  The placebo response rate and nocebo events in obesity pharmacological trials. A systematic review and meta-analysis.

Authors:  Yip Han Chin; Cheng Han Ng; Nicholas Ws Chew; Gwyneth Kong; Wen Hui Lim; Darren Jun Hao Tan; Kai En Chan; Ansel Tang; Daniel Q Huang; Mark Y Chan; Gemma Figtree; Jiong-Wei Wang; Asim Shabbir; Chin Meng Khoo; Vincent Wai-Sun Wong; Dan Yock Young; Mohammad Shadab Siddiqui; Mazen Noureddin; Arun Sanyal; David E Cummings; Nicholas Syn; Mark Dhinesh Muthiah
Journal:  EClinicalMedicine       Date:  2022-09-29

Review 9.  Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease.

Authors:  Youn Huh; Yoon Jeong Cho; Ga Eun Nam
Journal:  J Obes Metab Syndr       Date:  2022-03-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.